2024-04-01 2025-03-31 false Capium Accounts Production 1.1 12532261 2024-04-01 2025-03-31 12532261 bus:AbridgedAccounts 2024-04-01 2025-03-31 12532261 bus:FRS102 2024-04-01 2025-03-31 12532261 bus:AuditExempt-NoAccountantsReport 2024-04-01 2025-03-31 12532261 bus:SmallCompaniesRegimeForAccounts 2024-04-01 2025-03-31 12532261 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 12532261 2024-04-01 2025-03-31 12532261 2025-03-31 12532261 bus:RegisteredOffice 2024-04-01 2025-03-31 12532261 core:WithinOneYear 2025-03-31 12532261 core:AfterOneYear 2025-03-31 12532261 1 2024-04-01 2025-03-31 12532261 bus:Director1 2024-04-01 2025-03-31 12532261 bus:Director1 2025-03-31 12532261 bus:Director1 2023-04-01 2024-03-31 12532261 2023-04-01 12532261 bus:LeadAgentIfApplicable 2024-04-01 2025-03-31 12532261 2023-04-01 2024-03-31 12532261 2024-03-31 12532261 core:WithinOneYear 2024-03-31 12532261 core:AfterOneYear 2024-03-31 12532261 bus:EntityAccountantsOrAuditors 2023-04-01 2024-03-31 12532261 bus:OrdinaryShareClass1 2024-04-01 2025-03-31 12532261 bus:OrdinaryShareClass1 2025-03-31 12532261 bus:OrdinaryShareClass1 2023-04-01 2024-03-31 12532261 bus:OrdinaryShareClass1 2024-03-31 12532261 core:CostValuation core:Non-currentFinancialInstruments 2025-03-31 12532261 core:CostValuation core:Non-currentFinancialInstruments 2024-03-31 12532261 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2025-03-31 12532261 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2025-03-31 12532261 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-03-31 12532261 core:Non-currentFinancialInstruments 2025-03-31 12532261 core:Non-currentFinancialInstruments 2024-03-31 12532261 core:ShareCapital 2025-03-31 12532261 core:ShareCapital 2024-03-31 12532261 core:RetainedEarningsAccumulatedLosses 2025-03-31 12532261 core:RetainedEarningsAccumulatedLosses 2024-03-31 12532261 dpl:Item1 2024-04-01 12532261 dpl:Item1 2025-03-31 12532261 dpl:Item1 2023-04-01 12532261 dpl:Item1 2024-03-31 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 12532261
England and Wales

 

 

 

MEDIZ LIMITED



Abridged Accounts
 


Period of accounts

Start date: 01 April 2024

End date: 31 March 2025
 
 
Notes
 
2025
£
  2024
£
Current assets      
Debtors 42,000   
Cash at bank and in hand 1    89,688 
42,001    89,688 
Creditors: amount falling due within one year   (20,074)
Net current assets 42,001    69,614 
 
Total assets less current liabilities 42,001    69,614 
Net assets 42,001    69,614 
 

Capital and reserves
     
Called up share capital 3 100    100 
Profit and loss account 41,901    69,514 
Shareholders' funds 42,001    69,614 
 


For the year ended 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:
  1. The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
  2. The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006, the income statement has not been delivered to the Registrar of Companies.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with section 444(2A).
The financial statements were approved by the director on 02 December 2025 and were signed by:


-------------------------------
Aftabs Udins
Director
1
General Information
Mediz Limited is a private company, limited by shares, registered in England and Wales, registration number 12532261, registration address 37 Cardigan crescent, Weston Super Mare, BS22 8NS.

The presentation currency is £ sterling.
1.

Accounting policies

Significant accounting policies
Statement of compliance
These financial statements have been prepared in compliance with FRS 102 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.
Basis of preparation
The financial statements have been prepared under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies.
The financial statements are prepared in sterling which is the functional currency of the company.
Turnover
Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts.
2.

Average number of employees

Average number of employees during the year was 1 (2024 : 1).
3.

Share Capital

Allotted, called up and fully paid
2025
£
  2024
£
100 Class A shares of £1.00 each 100    100 
100    100 

2